相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Testicular germ cell tumor susceptibility associated with the UCK2 locus on chromosome 1q23
Fredrick R. Schumacher et al.
HUMAN MOLECULAR GENETICS (2013)
Investigational agents in development for the treatment of ovarian cancer
Shannon N. Westin et al.
INVESTIGATIONAL NEW DRUGS (2013)
Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
John Farley et al.
LANCET ONCOLOGY (2013)
Betaglycan Alters NFκB-TGFβ2 Cross Talk to Reduce Survival of Human Granulosa Tumor Cells
Maree Bilandzic et al.
MOLECULAR ENDOCRINOLOGY (2013)
The Changing View of High-Grade Serous Ovarian Cancer
Els M. J. J. Berns et al.
CANCER RESEARCH (2012)
Treatment of Ovarian Cancer in Young Women
David M. Gershenson
CLINICAL OBSTETRICS AND GYNECOLOGY (2012)
Role of Farletuzumab in Epithelial Ovarian Carcinoma
Danijela Jelovac et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Molecular Pathogenesis of Granulosa Cell Tumors of the Ovary
Stacey Jamieson et al.
ENDOCRINE REVIEWS (2012)
Associations between variants in KITLG, SPRY4, BAK1, and DMRT1 and pediatric germ cell tumors
Jenny N. Poynter et al.
GENES CHROMOSOMES & CANCER (2012)
Clinical trials and future potential of targeted therapy for ovarian cancer
Hiroaki Itamochi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2012)
Randomized, Double-Blind, Placebo-Controlled Phase II Study of AMG 386 Combined With Weekly Paclitaxel in Patients With Recurrent Ovarian Cancer
Beth Y. Karlan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Aromatase inhibitors in the treatment of recurrent ovarian granulosa cell tumors: Brief report and review of the literature
Mariam M. AlHilli et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2012)
Leydig Cell Tumors in Children: Contrasting Clinical, Hormonal, Anatomical, and Molecular Characteristics in Boys and Girls
Patricia Olivier et al.
JOURNAL OF PEDIATRICS (2012)
Bone morphogenetic protein signaling transcription factor (SMAD) function in granulosa cells
Stephanie A. Pangas
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2012)
Characterization of the Mechanism of Action of the Pan Class I PI3K Inhibitor NVP-BKM120 across a Broad Range of Concentrations
Saskia M. Brachmann et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Recurrent Somatic DICER1 Mutations in Nonepithelial Ovarian Cancers
Alireza Heravi-Moussavi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The Transcriptional Targets of Mutant FOXL2 in Granulosa Cell Tumours
Roseanne Rosario et al.
PLOS ONE (2012)
FOXL2 Is a Sensitive and Specific Marker for Sex Cord-Stromal Tumors of the Ovary
Osama M. Al-Agha et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)
A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study
J. J. Biagi et al.
ANNALS OF ONCOLOGY (2011)
Molecular approaches to personalizing management of ovarian cancer
R. C. Bast
ANNALS OF ONCOLOGY (2011)
KIT Gene Mutation and Amplification in Dysgerminoma of the Ovary
Liang Cheng et al.
CANCER (2011)
Deciphering the Role of Forkhead Transcription Factors in Cancer Therapy
Jer-Yen Yang et al.
CURRENT DRUG TARGETS (2011)
Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors
Anniina Farkkila et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
FOXL2 C402G mutation detection using MALDI-TOF-MS in DNA extracted from Israeli granulosa cell tumors
Rotem Gershon et al.
GYNECOLOGIC ONCOLOGY (2011)
Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours
N. Fustino et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2011)
Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial
Daniela Matei et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer
Jonathan A. Ledermann et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
Timothy A. Yap et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W)
J-H Kim et al.
ONCOGENE (2011)
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
William H. Chappell et al.
ONCOTARGET (2011)
Nuclear Receptor Profiling of Ovarian Granulosa Cell Tumors
Maria Alexiadis et al.
Hormones & Cancer (2011)
A Phase 2 Study of the Oral Mammalian Target of Rapamycin Inhibitor, Everolimus, in Patients With Recurrent Endometrial Carcinoma
Brian M. Slomovitz et al.
CANCER (2010)
Malignant Germ Cell Tumors Display Common MicroRNA Profiles Resulting in Global Changes in Expression of Messenger RNA Targets
Roger D. Palmer et al.
CANCER RESEARCH (2010)
A new target for proteasome inhibitors: FoxM1
Andrei L. Gartel
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment
E. Despierre et al.
GYNECOLOGIC ONCOLOGY (2010)
A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer
Michael Friedlander et al.
GYNECOLOGIC ONCOLOGY (2010)
The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary
Stacey Jamieson et al.
MODERN PATHOLOGY (2010)
Targeted therapies for rare gynaecological cancers
Tarinee Manchana et al.
LANCET ONCOLOGY (2010)
Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer
Clare Turnbull et al.
NATURE GENETICS (2010)
Aromatase Is a Direct Target of FOXL2: C134W in Granulosa Cell Tumors via a Single Highly Conserved Binding Site in the Ovarian Specific Promoter
Nicholas I. Fleming et al.
PLOS ONE (2010)
A mini-review of familial ovarian germ cell tumors: An additional manifestation of the familial testicular germ cell tumor syndrome
Claudia Giambartolomei et al.
CANCER EPIDEMIOLOGY (2009)
Somatic Sex Reprogramming of Adult Ovaries to Testes by FOXL2 Ablation
N. Henriette Uhlenhaut et al.
CELL (2009)
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study
Carol Aghajanian et al.
GYNECOLOGIC ONCOLOGY (2009)
Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors
Xia Tao et al.
GYNECOLOGIC ONCOLOGY (2009)
Expression Status and Mutational Analysis of the PTEN and PI3K Subunit Genes in Ovarian Granulosa Cell Tumors
Sophie Bittinger et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Promising Effect of Aromatase Inhibitors on Recurrent Granulosa Cell Tumors
Jacob Korach et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2009)
Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
Ursula A. Matulonis et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Loss of Betaglycan Contributes to the Malignant Properties of Human Granulosa Tumor Cells
Maree Bilandzic et al.
MOLECULAR ENDOCRINOLOGY (2009)
A genome-wide association study of testicular germ cell tumor
Elizabeth A. Rapley et al.
NATURE GENETICS (2009)
Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
Sohrab P. Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Proteasome Inhibition by Bortezomib Decreases Proliferation and Increases Apoptosis in Ovarian Granulosa Cell Tumors
Simon Chu et al.
REPRODUCTIVE SCIENCES (2009)
Advances in the development of cancer therapeutics directed against the RAS-mitogen-activated protein kinase pathway
Judith S. Sebolt-Leopold
CLINICAL CANCER RESEARCH (2008)
The use of bevacizumab in refractory ovarian granulosa-cell carcinoma with symptomatic relief of ascites: A case report
Joshua P. Kesterson et al.
GYNECOLOGIC ONCOLOGY (2008)
Phase II evaluation of imatinib mesylate in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
Russell J. Schilder et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The PTEN-PI3K pathway: of feedbacks and cross-talks
A. Carracedo et al.
ONCOGENE (2008)
Mechanisms for oncogenic activation of the epidermal growth factor
Roza Zandi et al.
CELLULAR SIGNALLING (2007)
Management of ovarian stromal cell tumors
Nicoletta Colombo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
A phase II trial of the mTOR inhibitor AP23573 as a single agent in advanced endometrial cancer
N. Colombo et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children
Nicolas Kalfa et al.
FERTILITY AND STERILITY (2007)
Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers
Christina E. Hoei-Hansen et al.
MOLECULAR CANCER (2007)
Anastrozole therapy in recurrent ovarian adult granulosa cell tumors: A report of 2 cases
Stephanie A. Freeman et al.
GYNECOLOGIC ONCOLOGY (2006)
TGF-β superfamily members and ovarian follicle development
Phil G. Knight et al.
REPRODUCTION (2006)
Activating mutations of the stimulatory G protein in juvenile ovarian granulosa cell tumors: A new prognostic factor?
N Kalfa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Ovarian granulosa cell tumors frequently express EGFR (Her-1), Her-3, and Her-4: An immunohistochemical study
S Leibl et al.
GYNECOLOGIC ONCOLOGY (2006)
Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis
P Cossu-Rocca et al.
MODERN PATHOLOGY (2006)
Activation of wnt/β-catenin signaling in distinct histologic subtypes of human germ cell tumors
Michael K. Fritsch et al.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY (2006)
Genome-wide linkage screen for testicular germ cell tumour susceptibility loci
GP Crockford et al.
HUMAN MOLECULAR GENETICS (2006)
GnRH antagonist in the adjuvant treatment of a recurrent ovarian granulosa cell tumor: A case report
L Ameryckx et al.
GYNECOLOGIC ONCOLOGY (2005)
Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications
M Sever et al.
MODERN PATHOLOGY (2005)
Molecular cytogenetics of ovarian granulosa cell tumors by comparative genomic hybridization
YS Lin et al.
GYNECOLOGIC ONCOLOGY (2005)
Hormonal treatment of a recurrent granulosa cell tumor of the ovary: case report and review of the literature
RD Hardy et al.
GYNECOLOGIC ONCOLOGY (2005)
Signalling pathways in the molecular pathogenesis of ovarian granulosa cell tumours
PJ Fuller et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
The transforming growth factor-β superfamily of receptors
M de Caestecker
CYTOKINE & GROWTH FACTOR REVIEWS (2004)
Transrepression of estrogen receptor β signaling by nuclear factor-κB in ovarian granulosa cells
S Chu et al.
MOLECULAR ENDOCRINOLOGY (2004)
Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development
M Uda et al.
HUMAN MOLECULAR GENETICS (2004)
The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome
L Crisponi et al.
NATURE GENETICS (2001)
分享论文
